SolveBio

SolveBio has developed an advanced precision medicine technology platform — called Genomic Intelligence Platform — that enables biopharma customers to lower trial risk, create more effective therapeutics, and compress the time scale of clinical development. The company's technology can connect genomic data to outcomes from a rapidly compounding complex landscape of vendors, studies, and patients.